Literature DB >> 11470194

Quantitative determination of piroxicam in a new formulation (piroxicam-beta-cyclodextrin) by derivative UV spectrophotometric method and HPLC.

H Basan1, N G Göğer, N Ertaş, M T Orbey.   

Abstract

A derivative ultraviolet (UV) spectrophotometric method for the determination of piroxicam in piroxicam--beta-cyclodextrin tablets was developed. Phosphate buffer (pH 7.8, 0.1 M) and ethanol were used as a solvent system throughout the study. In this study, determination of piroxicam was conducted by using first order derivative amplitudes at 261.4 nm (n=4). Standards for the calibration graph ranging from 2.40 to 20.0 microg/ml were prepared from working standard. The proposed method is accurate with 99.70%+/-0.50 recovery value and precise with coefficient of variation (CV) of 1.29. The results were compared with those obtained using a high-performance liquid chromatography (HPLC) procedure. A reversed-phase C(18) column with aqueous phosphate buffer:methanol, 60:40, v/v, mobile phase was used. UV detector was set at 254 nm. Calibration solutions used in HPLC were ranging from 5 to 20 microg/ml. Results obtained in HPLC were comparable to those obtained by derivative UV spectrophotometric method.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470194     DOI: 10.1016/s0731-7085(01)00383-1

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Analysis of piroxicam in pharmaceutical formulation and human urine by dispersive liquid-liquid microextraction combined with spectrophotometry.

Authors:  Ahad Bavili Tabrizi; Nakisa Seyyedeh Tutunchi
Journal:  Adv Pharm Bull       Date:  2013-02-07

2.  Validated method for the determination of piroxicam by capillary zone electrophoresis and its application to tablets.

Authors:  Arın Gül Dal; Zeynep Oktayer; Dilek Doğrukol-Ak
Journal:  J Anal Methods Chem       Date:  2014-09-09       Impact factor: 2.193

3.  In Vitro and Ex Vivo Evaluation of Tablets Containing Piroxicam-Cyclodextrin Complexes for Buccal Delivery.

Authors:  Eleni Kontogiannidou; Martina Ferrari; Asteria-Danai Deligianni; Nikolaos Bouropoulos; Dimitrios A Andreadis; Milena Sorrenti; Laura Catenacci; Kazem Nazari; Muhammad Sohail Arshad; Ming-Wei Chang; Zeeshan Ahmad; Dimitrios G Fatouros
Journal:  Pharmaceutics       Date:  2019-08-08       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.